Cerus Corp (CERS)

$1.51 +0.13 (9.42%)
Market Cap 242.77M
Revenue (ttm) 201.32M
Net Income (ttm) -20.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.39%
Debt to Equity Ratio 1.51
Volume 4,340,800
Avg Vol 1,248,806
Day's Range N/A - N/A
Shares Out 191.16M
Stochastic %K 57%
Beta 1.58
Analysts Strong Sell
Price Target $4.67

Latest News on CERS

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 3 days ago

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 29, 2025, 8:30 AM EDT - 8 days ago

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

May 28, 2025, 8:30 AM EDT - 9 days ago

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:26 PM EDT - 5 weeks ago

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2025 Financial Results

May 1, 2025, 4:00 PM EDT - 5 weeks ago

Cerus Corporation Announces First Quarter 2025 Financial Results

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Apr 17, 2025, 8:30 AM EDT - 7 weeks ago

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Mar 5, 2025, 1:00 PM EST - 3 months ago

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:50 PM EST - 3 months ago

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Feb 20, 2025, 4:00 PM EST - 3 months ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 4:00 PM EST - 3 months ago

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Feb 7, 2025, 8:30 AM EST - 4 months ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Jan 13, 2025, 8:30 AM EST - 5 months ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Cerus Corporation to Participate in Upcoming Investor Conferences

Nov 13, 2024, 8:30 AM EST - 7 months ago

Cerus Corporation to Participate in Upcoming Investor Conferences

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 11:52 PM EDT - 7 months ago

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:00 PM EDT - 7 months ago

Cerus Corporation Announces Third Quarter 2024 Financial Results

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 18, 2024, 8:30 AM EDT - 8 months ago

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Oct 18, 2024, 8:30 AM EDT - 8 months ago

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Oct 16, 2024, 4:00 PM EDT - 8 months ago

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:29 PM EDT - 11 months ago

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Aug 1, 2024, 4:00 PM EDT - 11 months ago

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 11 months ago

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Jul 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Jun 21, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Cerus Corporation Celebrates World Blood Donor Day 2024

Jun 14, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Celebrates World Blood Donor Day 2024

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:37 PM EDT - 1 year ago

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2024 Financial Results

May 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces First Quarter 2024 Financial Results

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:43 PM EST - 1 year ago

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Mar 5, 2024, 4:00 PM EST - 1 year ago

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Feb 20, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Jan 8, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 10:52 PM EDT - 1 year ago

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Cerus Corporation Announces Third Quarter 2023 Financial Results

Nov 2, 2023, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Third Quarter 2023 Financial Results

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Nov 1, 2023, 2:46 PM EDT - 1 year ago

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Oct 19, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Oct 10, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

Sep 27, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

Sep 12, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

Cerus Corporation Announces Second Quarter 2023 Financial Results

Aug 2, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces Second Quarter 2023 Financial Results

Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023

Jul 19, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023

Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress

Jun 15, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress

Cerus Corporation Celebrates World Blood Donor Day 2023

Jun 14, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2023

Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

Jun 5, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

Cerus Corporation: Cash Burn Remains Concerning

May 10, 2023, 3:41 PM EDT - 2 years ago

Cerus Corporation: Cash Burn Remains Concerning

Cerus Corporation (CERS) Q1 2023 Earnings Call Transcript

May 4, 2023, 9:10 PM EDT - 2 years ago

Cerus Corporation (CERS) Q1 2023 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2023 Financial Results

May 4, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces First Quarter 2023 Financial Results

Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

Apr 20, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023